Drug minimization in transplantation: an opinion.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Opinion in Organ Transplantation

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MOT.0000000000000099PMID 24991978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

  2014cited by this paper
• Control of innate immunological mechanisms as a route to drug minimization

  2014cited by this paper
• Induction of tolerance through mixed chimerism.

  2014cited by this paper
• Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells

  2014cited by this paper
• Megadose stem cell administration as a route to mixed chimerism.

  2014cited by this paper
• Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection

  2014cited by this paper
• Homeostatic expansion as a barrier to lymphocyte depletion strategies

  2014cited by this paper
• Dendritic cells of myeloid lineage: the masterminds behind acute allograft rejection

  2014cited by this paper

• Analytical and Clinical Validation of a Novel Blood-Based Biomarker of Liver Transplant Rejection

  2021cites this paper
• Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers.

  2020cites this paper
• The Real-life Experience of Developing and Commercializing TruGraf, a Validated Non-Invasive Transplant Biomarker

  2020cites this paper
• Haploidentical hematopoietic stem cell transplantation: state of art

  2015cites this paper